Recruiting NCT03807687

Registry of Pancreatic Disease

— Observational Pancreatic Diseases Pancreatic Neoplasms Pancreatitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Pancreatic Diseases, Pancreatic Neoplasms, Pancreatitis. Basic parameters: from 18 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Italy
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Registry of Subjects Affected by Pancreatic Disease and Evaluated at the Pancreas Institute of Verona

Overview

This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.

Primary outcome measures

Overall survival [Time frame: 1 year]

Secondary outcome measures (1)

Postoperative morbidity [Time frame: 90 days]

Eligibility criteria

Inclusion criteria

any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions)

Exclusion criteria

physically or mentally inability to provide consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model: Cohort

Study locations

Italy · 1 center

AOUI Verona — Verona

Identifiers

NCT: NCT03807687 · PAD-R 1101CESC

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗